J.J. Body - Concepedia

Author

J.J. Body

Université Libre de Bruxelles

Also Known As

J Body, J J Body, J-J Body, J-J. Body, J. Body, J. J. Body, J.-J Body, J.-J. Body, J.J. Body, JJ Body

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Université Libre de Bruxelles Institut Jules Bordet Centre Hospitalier Universitaire Brugmann Inserm University of Manchester

About

J.J. Body is an author at Université Libre de Bruxelles specializing in medicine, osteoporosis, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	495
2	Health Sciences	6	6	294
3	Cell Biology	1	1	51
4	Endocrinology	1	1	51
5	Metabolism	1	1	58

J.J. Body

Publications

904

Citations

H-Index

Page 1

	Year	Citations
Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia. J.J. Body, Pierre D. Delmas The Journal of Clinical Endocrinology & Metabolism Tumor-associated HypercalcemiaBone ResorptionParathyroid DiseaseOsteoporosisTumor Biology	1992	129
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases Benoit Beuselinck, Pascal Wolter, Alexandra Karadimou, British Journal of Cancer	2012	110
2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study Alison Stopeck, J.J. Body, Yasuyuki Fujiwara, European Journal of Cancer Supplements Breast OncologyOncologyBreast Cancer PatientsCancer ManagementRandomized Phase 3	2009	84
The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice Peter Schwarz, J.J. Body, Cáp J, European Journal of Endocrinology	2014	67
Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy J.J. Body, J.C. Dumon, Évelyne Gineyts, British Journal of Cancer Bone DiseaseBone HealthBone ResorptionOrthopaedic SurgeryHealth Sciences	1997	63
Heterogeneity of Metabolic Response to Systemic Therapy in Metastatic Breast Cancer Patients Valérie Huyge, C. Garcia, J. Alexiou, Clinical Oncology Metabolic SyndromeBreast OncologyOncologyMedicineMetabolic State	2010	58
Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival Olivia Fromigué, Naı̈ma Kheddoumi, J.J. Body British Journal of Cancer	2003	56
Extracellular calcium downregulates estrogen receptor alpha and increases its transcriptional activity through calcium-sensing receptor in breast cancer cells Fabrice Journé, J.C. Dumon, Naı̈ma Kheddoumi, Bone Breast OncologySignal TransductionMolecular PhysiologyExtracellular CalciumHormonal Receptor	2004	51
Aminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: A randomized comparison between a 3-day treatment and single 24-hour infusions J.J. Body, A. Magritte, F Seraj, Journal of Bone and Mineral Research	1989	49
Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy R. Rizzoli, D. Thiébaud, Nigel Bundred, The Journal of Clinical Endocrinology & Metabolism	1999	47

Page 1